Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

Approval Number

SIN15701P

Drug Name

IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

Product Name

IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML

Approval Date

May 29, 2019

Registrant

ADVAGEN PTE. LTD.

Licence Holder

ADVAGEN PTE. LTD.

Regulatory Information

Registrant

ADVAGEN PTE. LTD.

Licence Holder

ADVAGEN PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INFUSION, SOLUTION CONCENTRATE

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01XX19

ATC Item Name

xl 01 xx 19

Manufacturer Information

Pharmaceutical Manufacturer

ADVAGEN PTE. LTD.

Manufacturers

Sichuan Huiyu Pharmaceutical Co., Ltd

Active Ingredients

Ingredient Name

Irinotecan 17.33 mg/ml eqv Irinotecan Hydrochloride

Strength

20 mg/ ml

Drug MonographIrinotecan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy